The Delhi High Court in India has issued an injunction, restraining Sinopharm Weiqida from exporting its “Amoxycillin Trihydrate” product to India, as it infringes the patent of Centrient Pharmaceuticals

The High Court also found Sinopharm Weiqida guilty of Contempt of Court for failing to follow the previously granted preliminary injunction order

ROTTERDAM, the Netherlands, Feb. 19, 2019 (GLOBE NEWSWIRE) — Centrient Pharmaceuticals (“Centrient”), the leading manufacturer of

Read More